tyrosine has been researched along with quinidine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Bett, GC; Morales, MJ; Qu, YJ; Rasmusson, RL; Strauss, HC; Wang, S | 1 |
Ferrer, T; Navarro-Polanco, RA; Sănchez-Chapula, JA; Sanguinetti, MC | 1 |
Jebe, E; Petrunkina, AM; Töpfer-Petersen, E | 1 |
Bianchi, E; Cadet, P; Esch, T; Goumon, Y; Mantione, KJ; Shen, L; Sonetti, D; Stefano, GB; Zhu, W | 1 |
Dalvi, P; Gokulgandhi, M; Kesh, S; Kohli, T; Mitra, AK; Pal, D; Patel, M | 1 |
Holst, J | 1 |
Mitra, A | 1 |
8 other study(ies) available for tyrosine and quinidine
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect.
Topics: Allosteric Regulation; Amino Acid Sequence; Amino Acid Substitution; Animals; Dose-Response Relationship, Drug; Female; Kv1.4 Potassium Channel; Lysine; Molecular Sequence Data; Mutation; Oocytes; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Time Factors; Tyrosine; Xenopus laevis | 2003 |
Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.
Topics: Binding Sites; Cation Transport Proteins; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Membrane Proteins; Phosphodiesterase Inhibitors; Point Mutation; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Structure, Tertiary; Pyrazines; Quinidine; Quinine; Quinolines; Trans-Activators; Transcriptional Regulator ERG; Tyrosine | 2003 |
Regulatory and necrotic volume increase in boar spermatozoa.
Topics: Animals; Annexin A5; Cell Size; Chloride Channels; Enzyme Inhibitors; Hypertonic Solutions; Male; Necrosis; Phenols; Phosphoprotein Phosphatases; Phosphorylation; Protein-Tyrosine Kinases; Quinidine; Semen Preservation; Spermatozoa; Staining and Labeling; Staurosporine; Swine; Tamoxifen; Tyrosine; Vanadates | 2005 |
Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling.
Topics: alpha-Methyltyrosine; Animals; Base Sequence; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; DNA, Complementary; Dopamine; Enzyme Inhibitors; Ganglia, Invertebrate; Molecular Sequence Data; Morphine; Mytilus edulis; Quinidine; RNA, Messenger; Tyramine; Tyrosine; Tyrosine 3-Monooxygenase; Up-Regulation | 2005 |
Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells.
Topics: Biological Transport; Cell Culture Techniques; Cell Line, Tumor; Chromatography, Liquid; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity; Tandem Mass Spectrometry; Temperature; Time Factors; Tyrosine | 2013 |
Letter to the editor.
Topics: Humans; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Tyrosine | 2013 |
Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells [Int. J. Pharm. 443 (2013) 245-253].
Topics: Humans; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Tyrosine | 2013 |